Plantopia raises $9M to make cow-free dairy proteins as demand surges
What's the deal? Israeli food-tech company Plantopia has raised $9 million in a funding round led by dairy producer Schreiber Foods and food investment firm Siddhi CapitalDealroom has a profile for this one. Try Dealroom →. The money will fund a shift from research into commercial production of plant-based dairy proteins.
What's the endgame? Plantopia uses molecular farming — engineering plant sprouts to produce complex proteins usually derived from animals. Its first product is casein, the protein behind cheese structure, and the company says it is the first platform to produce all four major casein subtypes.
The goal: let manufacturers make lactose-free mozzarella and other dairy products without livestock, land, or sunlight.
Who else is in? Israeli investors AP PartnersDealroom has a profile for this one. Try Dealroom →, Tara Dairy, YotvataDealroom has a profile for this one. Try Dealroom →, and TempoDealroom has a profile for this one. Try Dealroom → also joined. Plantopia has now raised more than $16 million since it was founded in 2018 by Alexander Vainstein of the Hebrew University of Jerusalem, Tal Lutzky, and Amir Tiroler.
Why now? The round lands as demand for dairy proteins climbs, driven partly by GLP-1 weight-loss drugs. Roughly 12% of the US population uses weight-management drugs, and because these can cause muscle loss, higher protein intake is increasingly recommended.
Plantopia says US dairy protein consumption rose 83% over the past two years while prices climbed 250%. It also notes that about 70% of the global population has some degree of lactose intolerance.
What's next? The funding backs a manufacturing facility at Kibbutz Sdot Yam, expected to begin operations in the third quarter of 2026. "Having completed the development stages that have been our focus in recent years, we are now moving into commercial production," said chief executive officer and co-founder Tal Lutzky.
The signal: Plantopia is targeting the casein market, which it estimates is worth about $50 billion in North America alone. Rising protein demand and volatile dairy prices are opening room for alternatives that skip the cow — and, unlike fermentation-based rivals, avoid heavy capital investment.
Read more: CTech
Image credit: Generated with Gemini
